Description
Dexylan-60
is a modified-release capsule containing Dexlansoprazole 60 mg, formulated by ANVIS Laboratories to treat gastroesophageal reflux disease (GERD) and related acid-related disorders. Dexlansoprazole is a proton pump inhibitor (PPI) that reduces stomach acid production and provides long-lasting relief from heartburn, regurgitation, and esophagitis.
Each box includes 3 blister packs of 10 capsules, totaling 30 capsules, ideal for a full therapeutic course. The dual delayed-release technology ensures extended acid suppression throughout the day, making it suitable for both daytime and nighttime symptoms.
Dexylan-60 is recommended for patients with erosive esophagitis, persistent GERD, and those requiring maintenance therapy. It is well-tolerated and should be taken under medical supervision. The packaging features a vibrant design with a stomach illustration, reinforcing its digestive health focus.
